Literature DB >> 29850118

The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Thi Dan Linh Nguyen-Kim1, Britta Maurer2, Yossra A Suliman2,3, Fabian Morsbach1, Oliver Distler2, Thomas Frauenfelder1.   

Abstract

Background: To evaluate usability of slice-reduced sequential computed tomography (CT) compared to standard high-resolution CT (HRCT) in patients with systemic sclerosis (SSc) for qualitative and quantitative assessment of interstitial lung disease (ILD) with respect to (I) detection of lung parenchymal abnormalities, (II) qualitative and semiquantitative visual assessment, (III) quantification of ILD by histograms and (IV) accuracy for the 20%-cut off discrimination.
Methods: From standard chest HRCT of 60 SSc patients sequential 9-slice-computed tomography (reduced HRCT) was retrospectively reconstructed. ILD was assessed by visual scoring and quantitative histogram parameters. Results from standard and reduced HRCT were compared using non-parametric tests and analysed by univariate linear regression analyses.
Results: With respect to the detection of parenchymal abnormalities, only the detection of intrapulmonary bronchiectasis was significantly lower in reduced HRCT compared to standard HRCT (P=0.039). No differences were found comparing visual scores for fibrosis severity and extension from standard and reduced HRCT (P=0.051-0.073). All scores correlated significantly (P<0.001) to histogram parameters derived from both, standard and reduced HRCT. Significant higher values of kurtosis and skewness for reduced HRCT were found (both P<0.001). In contrast to standard HRCT histogram parameters from reduced HRCT showed significant discrimination at cut-off 20% fibrosis (sensitivity 88% kurtosis and skewness; specificity 81% kurtosis and 86% skewness; cut-off kurtosis ≤26, cut-off skewness ≤4; both P<0.001). Conclusions: Reduced HRCT is a robust method to assess lung fibrosis in SSc with minimal radiation dose with no difference in scoring assessment of lung fibrosis severity and extension in comparison to standard HRCT. In contrast to standard HRCT histogram parameters derived from the approach of reduced HRCT could discriminate at a threshold of 20% lung fibrosis with high sensitivity and specificity. Hence it might be used to detect early disease progression of lung fibrosis in context of monitoring and treatment of SSc patients.

Entities:  

Keywords:  Interstitial lung disease (ILD); histogram parameters from reduced high-resolution computed tomography (histogram parameters from reduced HRCT); reduced high-resolution computed tomography of the lung (reduced HRCT of the lung); systemic sclerosis (SSc)

Year:  2018        PMID: 29850118      PMCID: PMC5949494          DOI: 10.21037/jtd.2018.04.39

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  44 in total

1.  Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life.

Authors:  Gianna Camiciottoli; Ilaria Orlandi; Maurizio Bartolucci; Eleonora Meoni; Francesca Nacci; Stefano Diciotti; Chiara Barcaroli; Maria Letizia Conforti; Massimo Pistolesi; Marco Matucci-Cerinic; Mario Mascalchi
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

Review 2.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

3.  Computed tomography of the chest with model-based iterative reconstruction using a radiation exposure similar to chest X-ray examination: preliminary observations.

Authors:  Angeliki Neroladaki; Diomidis Botsikas; Sana Boudabbous; Christoph D Becker; Xavier Montet
Journal:  Eur Radiol       Date:  2012-08-15       Impact factor: 5.315

4.  Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study.

Authors:  Thomas Frauenfelder; Anna Winklehner; Thi Dan Linh Nguyen; Rucsandra Dobrota; Stephan Baumueller; Britta Maurer; Oliver Distler
Journal:  Ann Rheum Dis       Date:  2014-09-30       Impact factor: 19.103

5.  Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.

Authors:  Reoto Takei; Machiko Arita; Shogo Kumagai; Yuhei Ito; Fumiaki Tokioka; Takashi Koyama; Rintaro Saito; Keisuke Nishimura; Hironobu Tokumasu; Tadashi Ishida
Journal:  Respirology       Date:  2017-09-19       Impact factor: 6.424

6.  Visual vs Fully Automatic Histogram-Based Assessment of Idiopathic Pulmonary Fibrosis (IPF) Progression Using Sequential Multidetector Computed Tomography (MDCT).

Authors:  Davide Colombi; Julien Dinkel; Oliver Weinheimer; Berenike Obermayer; Teodora Buzan; Diana Nabers; Claudia Bauer; Ute Oltmanns; Karin Palmowski; Felix Herth; Hans Ulrich Kauczor; Nicola Sverzellati; Michael Kreuter; Claus Peter Heussel
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

7.  Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study.

Authors:  Jonathan Goldin; Robert Elashoff; Hyun J Kim; Xaiohong Yan; David Lynch; Diane Strollo; Michael D Roth; Philip Clements; Daniel E Furst; Dinesh Khanna; Srainnapha Vasunilashorn; Gang Li; Donald P Tashkin
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

8.  Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients.

Authors:  Takeshi Johkoh; Nestor L Müller; Thomas V Colby; Kazuya Ichikado; Hiroyuki Taniguchi; Yasuhiro Kondoh; Kiminori Fujimoto; Masaharu Kinoshita; Hiroaki Arakawa; Hidehiro Yamada; Moritaka Suga; Masayuki Ando; Mitsuhiro Koyama; Hironobu Nakamura
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

9.  Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.

Authors:  Tünde Minier; Serena Guiducci; Silvia Bellando-Randone; Cosimo Bruni; Gemma Lepri; László Czirják; Oliver Distler; Ulrich A Walker; Jaap Fransen; Yannick Allanore; Christopher Denton; Maurizio Cutolo; Alan Tyndall; Ulf Müller-Ladner; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2013-08-12       Impact factor: 19.103

10.  Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.

Authors:  Florian M P Meier; Klaus W Frommer; Robert Dinser; Ulrich A Walker; Laszlo Czirjak; Christopher P Denton; Yannick Allanore; Oliver Distler; Gabriela Riemekasten; Gabriele Valentini; Ulf Müller-Ladner
Journal:  Ann Rheum Dis       Date:  2012-05-21       Impact factor: 19.103

View more
  9 in total

1.  Erratum to the impact of slice-reduced computed tomography on histogram based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Authors:  Thi Dan Linh Nguyen-Kim; Britta Maurer; Yossra A Suliman; Fabian Morsbach; Oliver Distler; Thomas Frauenfelder
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 2.  Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Sydney B Montesi; Peter Caravan
Journal:  Curr Rheumatol Rep       Date:  2019-04-25       Impact factor: 4.592

3.  Circulating biomarkers of systemic sclerosis - interstitial lung disease.

Authors:  Anna-Maria Hoffmann-Vold; Håvard Fretheim; Chantal Meier; Britta Maurer
Journal:  J Scleroderma Relat Disord       Date:  2020-01-06

Review 4.  Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.

Authors:  Soumya Chatterjee; Apostolos Perelas; Ruchi Yadav; Donald F Kirby; Amandeep Singh
Journal:  Clin Rheumatol       Date:  2022-10-21       Impact factor: 3.650

Review 5.  Predictors of progression in systemic sclerosis patients with interstitial lung disease.

Authors:  Oliver Distler; Shervin Assassi; Vincent Cottin; Maurizio Cutolo; Sonye K Danoff; Christopher P Denton; Jörg H W Distler; Anna-Maria Hoffmann-Vold; Sindhu R Johnson; Ulf Müller Ladner; Vanessa Smith; Elizabeth R Volkmann; Toby M Maher
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671

6.  Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention.

Authors:  Aryeh Fischer; Nina M Patel; Elizabeth R Volkmann
Journal:  Open Access Rheumatol       Date:  2019-12-09

Review 7.  Paraclinical Aspects in Systemic Sclerosis.

Authors:  Carmen Bobeica; Mihaela Craescu; Bogdan Ioan Stefanescu; Ciprian Dinu; Iulia Chiscop; Silvia Chirobocea; Luiza Nechita; Alina Viorica Iancu; Victorita Stefanescu; Gabriela Balan; Ioana Anca Stefanopol; Ana Maria Pelin; Elena Niculet; Carmina Liana Musat; Alin Laurentiu Tatu
Journal:  Int J Gen Med       Date:  2022-04-26

Review 8.  Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.

Authors:  Dinesh Khanna; Oliver Distler; Vincent Cottin; Kevin K Brown; Lorinda Chung; Jonathan G Goldin; Eric L Matteson; Ella A Kazerooni; Simon Lf Walsh; Michael McNitt-Gray; Toby M Maher
Journal:  J Scleroderma Relat Disord       Date:  2022-01-03

9.  Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: proof of concept.

Authors:  K Martini; B Baessler; M Bogowicz; C Blüthgen; M Mannil; S Tanadini-Lang; J Schniering; B Maurer; T Frauenfelder
Journal:  Eur Radiol       Date:  2020-10-06       Impact factor: 5.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.